region stringclasses 1 value | symbol stringlengths 1 5 | exchange stringclasses 8 values | quote_type stringclasses 2 values | currency stringclasses 1 value | name stringlengths 2 84 ⌀ | sector stringclasses 12 values | industry stringclasses 148 values | close float64 0 5.92k ⌀ | volume float64 0 134M ⌀ | market_cap float64 22.4k 2,794B ⌀ | updated_at timestamp[ns] | long_business_summary stringlengths 50 5.19k ⌀ | status stringclasses 1 value | __index_level_0__ int64 0 7.31k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
US | ING | NYQ | EQUITY | USD | ING Groep N.V. | Financial Services | Banks - Diversified | 13.25 | 97,085 | 46,295,339,008 | 2023-10-17T13:35:43.693850 | ING Groep N.V., a financial institution, provides various banking products and services in the Netherlands, Belgium, Rest of Europe, North America, Latin America, Asia, and Australia. It operates in six segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The company accepts various deposits, such as current and savings accounts. It also offers business lending products; consumer lending products, such as residential mortgage loans, term loans, and other consumer lending loans; and secured and unsecured lending services. in addition, the company provides debt capital market, working capital solutions, export finance, daily banking, treasury and risk, and corporate finance solutions; and specialized lending, debt and equity market solutions, payments and cash management, and trade and treasury services, as well as savings, investment, insurance, mortgage, and digital banking services; and SME loans. It serves individual customers, corporate clients, and financial institutions. ING Groep N.V. was founded in 1762 and is headquartered in Amsterdam, the Netherlands. | null | 3,401 |
US | INGN | NMS | EQUITY | USD | Inogen, Inc. | Healthcare | Medical Devices | 4.89 | 6,505 | 113,653,056 | 2023-10-17T13:35:50.585710 | Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; and related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. | null | 3,402 |
US | INGR | NYQ | EQUITY | USD | Ingredion Incorporated | Consumer Defensive | Packaged Foods | 92.58 | 5,596 | 6,126,584,832 | 2023-10-17T13:35:58.675590 | Ingredion Incorporated, together with its subsidiaries, produces and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers starch products for use in a range of processed foods; cornstarch; specialty paper starches for enhanced drainage, fiber retention, oil and grease resistance, improved printability, and biochemical oxygen demand control; starches and specialty starches for textile industry; industrial starches are used in the production of construction materials, textiles, adhesives, pharmaceuticals, and cosmetics, as well as in mining and water filtration; and specialty industrial starches for use in biomaterial applications, including biodegradable plastics, fabric softeners and detergents, hair and skin care applications, dusting powders for surgical gloves, and in the production of glass fiber and insulation. It also provides sweetener products comprising glucose syrups, high maltose syrup, high fructose corn syrup, dextrose, polyols, maltodextrin, glucose syrup solids, and non-genetically modified organism syrups for use in food and beverage products, such as baked goods, snack foods, canned fruits, condiments, candy and other sweets, dairy products, ice cream, jams and jellies, prepared mixes, table syrups, soft drinks, fruit-flavored drinks, and others. In addition, the company refined corn oil, corn gluten feed, and corn gluten meal; and other products, including fruit and vegetable products, such as concentrates, purees, and essences, as well as pulse proteins and hydrocolloids systems and blends. The company was formerly known as Corn Products International, Inc. and changed its name to Ingredion Incorporated in June 2012. Ingredion Incorporated was founded in 1906 and is headquartered in Westchester, Illinois. | null | 3,403 |
US | INKM | PCX | ETF | USD | SPDR SSgA Income Allocation ETF | null | null | 28.5715 | 3,071 | 67,976,576 | 2023-10-17T13:36:04.290009 | The Adviser primarily invests the assets of the fund among ETPs that provide exposure to five primary asset classes: (i) domestic and international equity securities; (ii) domestic and international investment-grade and high yield debt securities; (iii) hybrid equity/debt securities; (iv) first lien senior secured floating rate bank loans, commonly referred to as "Senior Loans"; and (v) REITs, including equity REITs and mortgage REITs. | null | 3,404 |
US | INKT | NCM | EQUITY | USD | MiNK Therapeutics, Inc. | Healthcare | Biotechnology | 1.1 | 734 | 37,959,132 | 2023-10-17T13:36:11.673226 | MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. It's product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases and solid tumours, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York. | null | 3,405 |
US | INLX | ASE | EQUITY | USD | Intellinetics, Inc. | Technology | Software - Application | 5.1 | 1,935 | 20,776,176 | 2023-10-17T13:36:19.990527 | Intellinetics, Inc. designs, develops, tests, markets, and licenses document services and software solutions in the United States. The company operates in two segments, Document Management and Document Conversion. Its software platform allows its customers to capture and manage documents across operations, such as scanned hard-copy documents and digital documents, including Microsoft Office 365, digital images, audios, videos, and emails. The company's flagship software suite includes IntelliCloud platform that comprises image processing modules, records management, workflow, and extended components. It also provides installation, integration, training, and consulting services; ongoing software maintenance and customer support services; and digital scanning, microfilm and microfiche, box storage, scanning equipment, and software and repair services, as well as long-term paper and microfilm storage, and retrieval option services. In addition, the company offers business process outsourcing services. Intellinetics, Inc. sells its products to resellers and directly to customers, as well as provides access to its software solutions as a service through the Internet. It serves business and federal, county, and municipal governments, as well as healthcare, K-12 education, public safety, other public sector, risk management, financial services, and others. The company was formerly known as GlobalWise Investments, Inc. and changed its name to Intellinetics, Inc. in September 2014. Intellinetics, Inc. is headquartered in Columbus, Ohio. | null | 3,406 |
US | INM | NCM | EQUITY | USD | InMed Pharmaceuticals Inc. | Healthcare | Biotechnology | 0.6081 | 5,539 | 2,316,422 | 2023-10-17T13:36:27.903677 | InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products. The company operates through two segments, the InMed and the BayMedica. The InMed segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with high unmet medical needs. The company's lead product is INM-755, a cannabinol topical skin cream, completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-900 for neurodegenerative diseases. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach, for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada. | null | 3,407 |
US | INMB | NCM | EQUITY | USD | INmune Bio, Inc. | Healthcare | Biotechnology | 6.98 | 1,495 | 125,971,680 | 2023-10-17T13:36:34.058134 | INmune Bio, Inc., a clinical-stage immunology company, focuses on reprogramming the patient's innate immune system to treat cancer and neurodegenerative diseases. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma solid tumor and patients with high-risk myelodysplastic syndrome; INB03 to treat patients with cancers that express MUC4, a mucinous polyglucan on the surface of some epithelial cancer cells that appears to predict resistant to immunotherapy, including women with MUC4 expressing HER2+ breast cancer and other MUC4 resistant cancers; and XPro1595 for the treatment of Alzheimer's disease and Treatment Resistant Depression. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. The company was incorporated in 2015 and is headquartered in Boca Raton, Florida. | null | 3,408 |
US | INMD | NMS | EQUITY | USD | InMode Ltd. | Healthcare | Medical Devices | 21.32 | 184,323 | 1,774,497,664 | 2023-10-17T13:36:39.990122 | InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel. | null | 3,409 |
US | INN | NYQ | EQUITY | USD | Summit Hotel Properties, Inc. | Real Estate | REIT - Hotel & Motel | 5.88 | 12,366 | 637,931,584 | 2023-10-17T13:36:45.941524 | Summit Hotel Properties, Inc. is a publicly traded real estate investment trust focused on owning premium-branded lodging properties with efficient operating models primarily in the upscale segment of the lodging industry. As of August 2, 2023, the Company's portfolio consisted of 101 assets, 57 of which are wholly owned, with a total of 15,035 guestrooms located in 24 states. | null | 3,410 |
US | INNV | NMS | EQUITY | USD | InnovAge Holding Corp. | Healthcare | Medical Care Facilities | 5.84 | 70 | 807,115,328 | 2023-10-17T13:36:53.395280 | InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado. | null | 3,411 |
US | INO | NMS | EQUITY | USD | Inovio Pharmaceuticals, Inc. | Healthcare | Biotechnology | 0.518 | 303,736 | 139,398,992 | 2023-10-17T13:37:01.699382 | Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania. | null | 3,412 |
US | INOD | NGM | EQUITY | USD | Innodata Inc. | Technology | Information Technology Services | 7.19 | 13,535 | 204,540,176 | 2023-10-17T13:37:07.770720 | Innodata Inc. operates as a global data engineering company in the United States, the United Kingdom, the Netherlands, Canada, and internationally. The company operates through three segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment engages in the provision of AI data preparation services; collecting or creating training data; annotating training data; and training AI algorithms for its customers, as well as AI model deployment and integration services. This segment also provides a range of data engineering support services, including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management. The Synodex segment offers an industry platform that transforms medical records into useable digital data with its proprietary data models or client data models. The Agility segment provides an industry platform that offers marketing communications and public relations professionals to target and distribute content to journalists and social media influencers; and to monitor and analyze global news channels, such as print, web, radio, and TV, as well as social media channels. It serves banking, insurance, financial services, technology, digital retailing, and information/media sectors through its professional staff, senior management, and direct sales personnel. The company was formerly known as Innodata Isogen, Inc. and changed its name to Innodata Inc. in June 2012. Innodata Inc. was incorporated in 1988 and is headquartered in Ridgefield Park, New Jersey. | null | 3,413 |
US | INPX | NCM | EQUITY | USD | Inpixon | Technology | Software - Application | 0.107 | 643,215 | 11,906,367 | 2023-10-17T13:37:13.396450 | Inpixon, together with its subsidiaries, operates as an indoor intelligence company in the United States, Canada, India, Germany, Philippines, Ireland, the United Kingdom, and internationally. It operates through three segments: Indoor Intelligence, Saves, and Shoom. The Indoor Intelligence segment offers Internet of Things (IoT) software as a service platform that provides industrial IoT space, including enterprise class, multi-technology RTLS IoT platform for industrial automation; RTLS asset tracking hardware, such as end-to-end portfolio of IoT sensors, and tracking tags to track assets or personnel; Inpixon nanoLOC transceiver, a low-power, highly integrated mixed-signal chip; and video integration solution uses IoT analytics data and allows direct integration with leading video management systems and CCTV. This segment also provides augmented reality and 3D allow businesses to scan a space and attach AR content persistently to any position; analytics and insights, a cloud-based analytics platform allows data from multiple sensors and data sources to be visualized for action by the operator; and wireless device detection for security solutions cultivates situational awareness and identify security risks by leveraging sensors with proprietary technology that can detect and position active cellular, Wi-Fi, Bluetooth, and UWB signals. The Shoom segment offers digital solutions or cloud-based applications and analytics for the media and publishing industry, including eTearsheets and eInvoice. The Saves segments provide a set of data analytics and statistical visualization software solutions for engineers and scientists comprising SigmaPlot, SigmaStat, SYSTAT, PeakFit, TableCurve 2D, TableCurve 3D, SigmaScan, and MYSTAT. The company was formerly known as Sysorex Global and changed its name to Inpixon in March 2017. Inpixon is headquartered in Palo Alto, California. | null | 3,414 |
US | INSE | NCM | EQUITY | USD | Inspired Entertainment, Inc. | Consumer Cyclical | Gambling | 11.46 | 3,126 | 296,023,392 | 2023-10-17T13:37:19.812101 | Inspired Entertainment, Inc., a gaming technology company, engages in the supply of content, platform, and other products and services to regulated lottery, betting, and gaming operators worldwide. It operates in four segments: Gaming, Virtual Sports, Interactive, and Leisure. The Gaming segment supplies gaming terminals and software to betting offices, casinos, gaming halls, and high street adult gaming centers; a portfolio of games through its digital terminals under the Centurion and Super Hot Fruits names; and traditional casino games, such as roulette, blackjack, and number games. The Virtual Sports segment designs, develops, markets, and distributes ultra-high-definition sports games, including greyhounds, tennis, motor racing, cycling, cricket, speedway, golf, and dart, and other horse racing games under the V-Play Soccer, V-Play Women's Soccer, V-Play Football, V-Play Basketball, V-Play Baseball, and V-Play NFLA names. The Interactive segment provides a range of premium random number generated casino content from feature-rich bonus games to European-style casino free spins and table games. The Leisure segment supplies gaming terminals and amusement machines in pubs, bingo halls, and adult gaming centers, as well as family entertainment centers, bowling centers, and other entertainment venues. Inspired Entertainment, Inc. is headquartered in New York, New York. | null | 3,415 |
US | INSG | NMS | EQUITY | USD | Inseego Corp. | Technology | Communication Equipment | 0.39 | 6,227 | 47,099,820 | 2023-10-17T13:37:26.922175 | Inseego Corp. engages in the design and development of fixed and mobile wireless solutions, industrial Internet of Things (IIoT), and cloud solutions for large enterprise verticals, service providers, small and medium-sized businesses, governments, and consumers worldwide. The company provides wireless 4G and 5G hardware products, including private LTE/5G networks, First responders network authority/Firstnet, SD-WAN, telematics, remote monitoring and surveillance, and fixed wireless access and mobile broadband devices. Its products include 4G and 5G fixed wireless routers and gateways, mobile hotspots, and wireless gateways and routers for IIoT applications; and Gb speed 4G LTE hotspots and USB modems, integrated telematics, and mobile tracking hardware devices, which are supported by applications software and cloud services designed to enable customers to analyze data insights and configure/manage their hardware remotely. In addition, the company sells software-as-a-service (SaaS), software, and services solutions in various mobile and IIoT vertical markets comprising fleet management, vehicle telematics, stolen vehicle recovery, asset tracking, monitoring, business connectivity, and subscription management. Its SaaS delivery platforms include telematics, asset tracking, and management platforms which provide fleet, vehicle, aviation, asset, and other telematics applications; and Inseego Subscribe, a hosted SaaS platform that helps organizations in managing the selection, deployment, and spend of their customers wireless assets by helping them to save money on personnel and telecom expenses. The company was founded in 1996 and is based in San Diego, California. | null | 3,416 |
US | INSI | NYQ | EQUITY | USD | Insight Select Income Fund | Financial Services | Asset Management | 14.72 | 13,600 | 157,272,720 | 2023-10-17T13:37:34.156011 | Insight Select Income Fund is a closed ended fixed income mutual fund launched and managed by Cutwater Asset Management Corp. The fund invests in the fixed income markets of the United States. It primarily invests in short-term and long-term debt securities. The fund invests in the securities rated within the highest four grades by Moody's or Standard & Poor's, obligations of the U.S. Government, or obligations of banks. It benchmarks the performance of its portfolios against the Lehman Brothers Aggregate Bond TR Index. The fund was formerly known as Cutwater Select Income Fund. Insight Select Income Fund was formed on October 13, 1971 and is domiciled in the United States. | null | 3,417 |
US | INSM | NMS | EQUITY | USD | Insmed Incorporated | Healthcare | Biotechnology | 25.08 | 19,041 | 3,682,718,208 | 2023-10-17T13:37:41.929266 | Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis, cystic fibrosis, and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey. | null | 3,418 |
US | INSP | NYQ | EQUITY | USD | Inspire Medical Systems, Inc. | Healthcare | Medical Devices | 150.97 | 12,733 | 4,436,144,640 | 2023-10-17T13:37:49.810951 | Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. | null | 3,419 |
US | INST | NYQ | EQUITY | USD | Instructure Holdings, Inc. | Technology | Software - Application | 26.34 | 76,741 | 3,792,723,200 | 2023-10-17T13:37:56.510825 | Instructure Holdings, Inc. provides cloud-based learning, assessment, development, and engagement systems worldwide. It offers Canvas Learning Management System (LMS), for content creation, management, and delivery of face-to-face, blended, and online instruction; Canvas Studio, an online video platform, hosts, manages, edits, and delivers video learning experiences; Canvas Catalog, a course catalog and registration system for creating and maintaining a branded marketplace for online course offerings; Canvas Network, an invitation-only offering, to host and deliver large-scale online courses; Canvas Credentials, a digital badging solution, to provide learners with portable verification of skills in stackable pathways; and Canvas Student Pathways, a solution to guide students through customized learning paths culminating in digital certifications. The company also provides Mastery Assessment, a solution for assessment management and content that include Mastery Connect, a student Assessment Management System, and Mastery View Assessments and Mastery Item Banks, provides various assessment content solutions and analytics; and Impact, helps institutions to drive adoption of new technology tools and evaluate impact on student engagement and outcomes. In addition, it provides Elevate Data Sync, a solutions for synchronization of data, grades, and rosters between edtech applications and student information systems; Elevate K-12 Analytics, a data and analytics solution that delivers interactive visualizations and dashboards; Elevate Data Quality, a data-quality solution that ensures district data is accurate, complete, and up-to-date; Elevate Standards Alignment, to align standards-based educational content, improve discoverability, and reach new education markets; and LearnPlatform Tools offered to evaluate, select, and manage the ongoing usage and effectiveness of digital learning products. The company was founded in 2008 and is headquartered in Salt Lake City, Utah. | null | 3,420 |
US | INSW | NYQ | EQUITY | USD | International Seaways, Inc. | Energy | Oil & Gas Midstream | 45.93 | 12,693 | 2,264,077,568 | 2023-10-17T13:38:04.138011 | International Seaways, Inc. owns and operates a fleet of oceangoing vessels for the transportation of crude oil and petroleum products in the international flag trade. It operates in two segments: Crude Tankers and Product Carriers. It serves independent and state-owned oil companies, oil traders, refinery operators, and international government entities. The company was formerly known as OSG International, Inc. and changed its name to International Seaways, Inc. in October 2016. International Seaways, Inc. was incorporated in 1999 and is headquartered in New York, New York. | null | 3,421 |
US | INTA | NMS | EQUITY | USD | Intapp, Inc. | Technology | Software - Application | 35.86 | 11,167 | 2,487,926,528 | 2023-10-17T13:38:11.568064 | Intapp, Inc., through its subsidiary, Integration Appliance, Inc., provides industry-specific cloud-based software solutions for the professional and financial services industry in the United States, the United Kingdom, and internationally. Its solutions include DealCloud, a deal and relationship management solution that manages financial services firms' market relationships, prospective clients and investments, current engagements and deal processes, and operations and compliance activities; collaboration and content solutions, including Intapp documents, an engagement-centric document management system, and Intapp workspaces; risk and compliance management solutions, such as Intapp conflicts, Intapp intake, Intapp terms, Intapp walls, and Intapp employee compliance; and operational and financial management solutions comprising Intapp Billstream, a cloud-based automated proforma invoice solution, Intapp time, and Intapp terms. The company's solutions enable private capital, investment banking, legal, accounting, and consulting firms to realize the benefits of modern AI and cloud-based architectures for their critical business functions without compromising industry-specific functionality or regulatory compliance. It also offers strategic advisory, operational transformation, technology and digital strategy, data strategy, risk management, change management, program management, and M&A preparation; implementation services; managed services; and technical support services, as well as collaboration and integration solutions. The company sells its software on a subscription basis through a direct enterprise sales model. The company was formerly known as LegalApp Holdings, Inc. and changed its name to Intapp, Inc. in February 2021. Intapp, Inc. was founded in 2000 and is headquartered in Palo Alto, California. | null | 3,422 |
US | INTC | NMS | EQUITY | USD | Intel Corporation | Technology | Semiconductors | 36.56 | 1,846,715 | 149,281,259,520 | 2023-10-17T13:38:18.097096 | Intel Corporation designs, develops, manufactures, markets, and sells computing and related products worldwide. It operates through Client Computing Group, Data Center and AI, Network and Edge, Mobileye, Accelerated Computing Systems and Graphics, Intel Foundry Services, and Other segments. The company offers platform products, such as central processing units and chipsets, and system-on-chip and multichip packages; and accelerators, boards and systems, connectivity products, and memory and storage products. It also provides high-performance computer solutions for targeted verticals and embedded applications for retail, industrial, and healthcare markets; and solutions for assisted and autonomous driving comprising compute platforms, computer vision and machine learning-based sensing, mapping and localization, driving policy, and active sensors. In addition, the company offers workload-optimized platforms and related products for cloud service providers, enterprise and government, and communications service providers. It serves original equipment manufacturers, original design manufacturers, cloud service providers, and other equipment manufacturers. The company has a strategic partnership with Synopsys, Inc. to develop EDA and IP solutions and a collaboration with Red Hat to. deliver open source industrial automation to the manufacturing shop floor. The company The company was incorporated in 1968 and is headquartered in Santa Clara, California. | null | 3,423 |
US | INTE | NGM | EQUITY | USD | Integral Acquisition Corporation 1 | Financial Services | Shell Companies | 10.72 | 19,406 | 63,300,960 | 2023-10-17T13:38:26.258351 | Integral Acquisition Corporation 1 does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology-oriented company in Australia and New Zealand. Integral Acquisition Corporation 1 was incorporated in 2021 and is based in New York, New York. | null | 3,424 |
US | INTF | PCX | ETF | USD | iShares International Equity Factor ETF | null | null | 25.78 | 2,165 | 938,988,736 | 2023-10-17T13:38:33.259891 | The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is composed of large- and mid-capitalization equity securities from the STOXX Global 1800 ex USA index (the “parent index”) that are selected and weighted using an optimization process designed to maximize exposure to five target factors: momentum, quality, value, low volatility and size. | null | 3,425 |
US | INTG | NCM | EQUITY | USD | The InterGroup Corporation | Consumer Cyclical | Lodging | 30.7 | 1 | 67,739,248 | 2023-10-17T13:38:41.425920 | The InterGroup Corporation, through its subsidiaries, operates a hotel under the Hilton San Francisco Financial District name located in San Francisco, California. The company operates through three segments: Hotel Operations, Real Estate Operations, and Investment Transactions. Its hotel consists of 544 guest rooms and luxury suites with approximately 22,000 square feet of meeting room space, a grand ballroom, 5-level underground parking garage, a pedestrian bridge, and a Chinese culture center. The company also invests in income-producing instruments, corporate debt and equity securities, publicly traded investment funds, mortgage-backed securities, securities issued by REITs, and other companies that invest primarily in real estate. As of June 30, 2022, it owned, managed, and invested in 16 apartment complexes, 3 single-family houses as strategic investments, and 1 commercial real estate property located in the United States, as well as owned approximately 2 acres of unimproved land in Maui, Hawaii. The company was founded in 1965 and is based in Los Angeles, California. | null | 3,426 |
US | INTR | NMS | EQUITY | USD | Inter & Co, Inc. | Financial Services | Banks - Regional | 4.19 | 110,829 | 1,678,768,768 | 2023-10-17T13:38:47.696119 | Inter & Co, Inc., through its subsidiaries, engages in the banking, securities, insurance brokerage, marketplace, asset management, and services businesses. The company's Banking segment offers banking products and services, including checking accounts, cards, deposits, loans and advances, and other services. Its Securities segment provides services relating to the purchase, sale, and custody of securities; and portfolio management, as well as the establishment, organization, and management of investment funds. The company's Insurance Brokerage segment offers life, property, auto, financial, lost or stolen credit card, dental, warranties, travel, and credit protection insurance products. Its Marketplace segment operates a digital platform that offer goods and/or services to its customers. The company's Asset Management segment is involved in the operations related to the management of fund portfolios and other assets. Its Services segment provides services in the collection and management of personal information; development and licensing of customized and non-customized computer programs; and technical support, maintenance, and other information technology services. The company was founded in 1994 and is based in Belo Horizonte, Brazil. | null | 3,427 |
US | INTS | NCM | EQUITY | USD | Intensity Therapeutics, Inc. | Healthcare | Biotechnology | 3.97 | 93 | 54,327,068 | 2023-10-17T13:38:55.958697 | Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. Its lead product candidate includes INT230-6, a clinical trial for the treatment of refractory solid tumors and pancreatic, colon, bile duct, squamous cell carcinoma, sarcoma, breast, and liver cancers. The company was incorporated in 2012 and is headquartered in Westport, Connecticut. | null | 3,428 |
US | INTT | ASE | EQUITY | USD | inTEST Corporation | Technology | Semiconductor Equipment & Materials | 14.51 | 2,334 | 176,526,912 | 2023-10-17T13:39:03.296143 | inTEST Corporation supplies test and process solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies. The Electronic Test segment provides in2(R), Cobal, and LS series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products, which protect the interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly. This segment also offers tester interfaces that provide electrical connections between the tester and the wafer prober or IC handler; scorpion flying probe test systems that designs and manufactures robotics-based electronic test equipment; and BRiZ automated test and programming services. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The Environmental Technologies segment offers ThermoStream products that are used in the semi market as a stand-alone temperature management tool, or in various electronic test applications; thermal chambers; thermal platforms; Thermonics temperature conditioning products that provide tempered gas or fluid; and ultra-cold storage solutions, including biomedical freezers, refrigerators, and mobile storage solutions. The Process Technologies segment provides EKOHEAT and EASYHEAT induction heating systems; and digital streaming and image capturing solutions. The company markets and sells its products to semiconductor manufacturers, third-party foundries, test and assembly providers, and original equipment manufacturers. inTEST Corporation was incorporated in 1981 and is headquartered in Mount Laurel, New Jersey. | null | 3,429 |
US | INTU | NMS | EQUITY | USD | Intuit Inc. | Technology | Software - Application | 540.9 | 44,744 | 149,846,081,536 | 2023-10-17T13:39:09.467378 | Intuit Inc. provides financial management and compliance products and services for consumers, small businesses, self-employed, and accounting professionals in the United States, Canada, and internationally. The company operates in four segments: Small Business & Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business & Self-Employed segment provides QuickBooks services, that includes financial and business management online services and desktop software, payroll solutions, time tracking, merchant payment processing solutions, and financing for small businesses; and Mailchimp services, such as e-commerce, marketing automation, and customer relationship management. This segment also offers QuickBooks online services and desktop software solutions comprising QuickBooks Online Advanced, a cloud-based solution; QuickBooks Enterprise, a hosted solution; and QuickBooks Self-Employed solution; payment-processing solutions, including credit and debit cards, Apple Pay, and ACH payment services; and financial supplies and financing for small businesses, as well as electronic filing of federal and state income tax returns. The Consumer segment provides TurboTax income tax preparation products and services. The Credit Karma segment offers consumers with a personal finance platform that provides personalized recommendations of home, auto, and personal loans, as well as credit cards and insurance products. The ProTax segment provides Lacerte, ProSeries, and ProFile desktop tax-preparation software products; and ProConnect Tax Online tax products, electronic tax filing service, and bank products and related services. It sells products and services through various sales and distribution channels, including multi-channel shop-and-buy experiences, websites and call centers, mobile application stores, and retail and other channels. The company was founded in 1983 and is headquartered in Mountain View, California. | null | 3,430 |
US | INTZ | NCM | EQUITY | USD | Intrusion Inc. | Technology | Software - Infrastructure | 0.3804 | 33,135 | 9,140,470 | 2023-10-17T13:39:15.060019 | Intrusion Inc., a cybersecurity company in the United States. The company offers its customers access to threat intelligence database, which contains the historical data, known associations, and reputational behavior of Internet Protocol addresses. It offers INTRUSION Shield, a cybersecurity solution based on security-as-a-service solution to identify and stop Zero-Day and ransomware attacks. The company also provides INTRUSION TraceCop, a big data tool that contains an inventory of network selectors and enrichments to support forensic investigations; and INTRUSION Savant, a network monitoring solution that uses the data available in TraceCop to identify suspicious traffic in real-time. In addition, it engages in the resale of standard commercially available computers and servers from various vendors; and provision of pre-and post-sales support services, such as network security design, system installation, and technical consulting services. The company serves US federal government entities, state and local government entities, and companies ranging from mid-market to large enterprises through a direct sales force and value-added resellers. The company was formerly known as Intrusion.com, Inc. and changed its name to Intrusion Inc. in November 2001. Intrusion Inc. was founded in 1983 and is headquartered in Plano, Texas. | null | 3,431 |
US | INUV | ASE | EQUITY | USD | Inuvo, Inc. | Communication Services | Advertising Agencies | 0.221 | 45,057 | 32,321,216 | 2023-10-17T13:39:21.892430 | Inuvo, Inc., a technology company, engages in the development and sale of information technology solutions for marketing and advertising industries in the United States. The company's platforms identify and message online audiences for various products or services across devices, formats, and channels, including video, mobile, connected TV, linear TV, display, social, search, and native. Its platforms optimize the purchase and placement of advertising in real time. The company's products and services include IntentKey, an artificial intelligence-based consumer intent recognition system designed to reach targeted mobile and desktop in-market audiences; and CampSight that provides marketing and advertising services, as well as collection of data, analytics, software, and publishing gets used to align merchant advertising messages with anonymous consumers across various websites online. It also operates a collection of websites under the Bonfire Publishing brand, which creates content across a range of topics, including health, finance, travel, careers, auto, education, and lifestyle categories. The company's marketing channels consist of websites, social media, blogs, public relations, trade shows, and conferences. Inuvo, Inc. was incorporated in 1987 and is headquartered in Little Rock, Arkansas. | null | 3,432 |
US | INVA | NMS | EQUITY | USD | Innoviva, Inc. | Healthcare | Biotechnology | 13.41 | 7,862 | 877,521,024 | 2023-10-17T13:39:27.174498 | Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company's products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA) and umeclidinium bromide (UMEC) with a LABA, VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. It has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California. | null | 3,433 |
US | INVE | NCM | EQUITY | USD | Identiv, Inc. | Technology | Computer Hardware | 7.55 | 129 | 175,555,184 | 2023-10-17T13:39:33.522526 | Identiv, Inc. operates as a security technology company that secures things, data, and physical places in the Americas, Europe, the Middle East, and the Asia-Pacific. The company operates in two segments, Identity and Premises. The Identity segment offers products and solutions that enables secure access to information serving the logical access and cyber security markets, as well as protecting connected objects and information using radio-frequency identification embedded security. The Premises segment provides solutions for premises security market, such as access control, video surveillance, analytics, audio, access readers, and identities to government facilities, schools, utilities, hospitals, stores, and apartment buildings. The company sells its products through dealers, systems integrators, value added resellers, and resellers. The company was formerly known as Identive Group, Inc. and changed its name to Identiv, Inc. in May 2014. Identiv, Inc. was founded in 1990 and is headquartered in Fremont, California. | null | 3,434 |
US | INVH | NYQ | EQUITY | USD | Invitation Homes Inc. | Real Estate | REIT - Residential | 32.69 | 57,600 | 20,137,000,960 | 2023-10-17T13:39:40.690119 | Invitation Homes, an S&P 500 company, is the nation's premier single-family home leasing company, meeting changing lifestyle demands by providing access to high-quality, updated homes with valued features such as close proximity to jobs and access to good schools. The company's mission, "Together with you, we make a house a home," reflects its commitment to providing homes where individuals and families can thrive and high-touch service that continuously enhances residents' living experiences. | null | 3,435 |
US | INVO | NCM | EQUITY | USD | INVO Bioscience, Inc. | Healthcare | Medical Devices | 0.646 | 289 | 1,646,692 | 2023-10-17T13:39:46.950865 | INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida. | null | 3,436 |
US | INVZ | NCM | EQUITY | USD | Innoviz Technologies Ltd. | Consumer Cyclical | Auto Parts | 1.63 | 34,678 | 265,911,680 | 2023-10-17T13:39:52.835750 | Innoviz Technologies Ltd. designs and manufactures solid-state LiDAR sensors and develops perception software that enables the mass production of autonomous vehicles. The company manufactures InnovizOne, a solid-state LiDAR sensor designed for automakers and robotaxi, shuttle, trucking, and delivery companies requiring an automotive-grade and mass-producible solution to achieve autonomy. Its automotive-grade sensor is integrable into Level 3 through 5 autonomous vehicles for the safety of passengers and pedestrians. The company also provides InnovizTwo, an automotive-grade LiDAR sensor that offers a solution for all levels of autonomous driving, as well as an option to integrate the perception application in the LiDAR sensor; Innoviz360, a 360-degree LiDAR for automotive and non-automotive applications; and perception application, a software application that turns the InnovizOne LiDAR's raw point cloud data into perception outputs to provide scene perception and deliver an automotive-grade ASIL B(D) solution. It operates in Europe, Asia Pacific, the Middle East, Africa, and North America. The company was incorporated in 2016 and is headquartered in Rosh HaAyin, Israel. | null | 3,437 |
US | INZY | NMS | EQUITY | USD | Inozyme Pharma, Inc. | Healthcare | Biotechnology | 3.35 | 7,336 | 213,650,816 | 2023-10-17T13:39:59.988725 | Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases in the United States. The company's lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein, which is in Phase 1/2 clinical trials for the treatment of ENPP1 and ABCC6 deficiency, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. | null | 3,438 |
US | IOAC | NGM | EQUITY | USD | Innovative International Acquisition Corp. | Financial Services | Shell Companies | 11.35 | 1,132 | 134,161,544 | 2023-10-17T13:40:07.742862 | Innovative International Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business transaction with one or more businesses in consumer technology, healthcare, information technology services, and enterprise software as a service. The company was incorporated in 2021 and is based in Dana Point, California. | null | 3,439 |
US | IOBT | NMS | EQUITY | USD | IO Biotech, Inc. | Healthcare | Biotechnology | 1.11 | 144 | 77,432,624 | 2023-10-17T13:40:13.074756 | IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark. | null | 3,440 |
US | IONM | NCM | EQUITY | USD | Assure Holdings Corp. | Healthcare | Medical Care Facilities | 0.335 | 51,184 | 2,083,342 | 2023-10-17T13:40:18.973838 | Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. Assure Holdings Corp. is based in Englewood, Colorado. | null | 3,441 |
US | IONQ | NYQ | EQUITY | USD | IonQ, Inc. | Technology | Computer Hardware | 14.41 | 893,174 | 2,841,394,944 | 2023-10-17T13:40:26.413508 | IonQ, Inc. engages in the development of general-purpose quantum computing systems in the United States. It sells access to quantum computers of various qubit capacities. The company makes access to its quantum computers through cloud platforms, such as Amazon Web Services (AWS) Amazon Braket, Microsoft's Azure Quantum, and Google's Cloud Marketplace, as well as through its cloud service. The company also provides consulting services related to co-developing algorithms on quantum computing systems; and contracts associated with the design, development, and construction of specialized quantum computing systems. IonQ, Inc. was founded in 2015 and is headquartered in College Park, Maryland. | null | 3,442 |
US | IONR | NCM | EQUITY | USD | ioneer Ltd | Basic Materials | Other Industrial Metals & Mining | 5.1 | 4,362 | 246,554,944 | 2023-10-17T13:40:31.765650 | ioneer Ltd explores for and develops mineral properties in North America. Its flagship property is the Rhyolite Ridge lithium-boron project located in the state of Nevada, the United States. The company was formerly known as Global Geoscience Limited and changed its name to ioneer Ltd in November 2018. The company was incorporated in 2001 and is based in North Sydney, Australia. | null | 3,443 |
US | IONS | NMS | EQUITY | USD | Ionis Pharmaceuticals, Inc. | Healthcare | Biotechnology | 48.14 | 43,901 | 6,899,355,648 | 2023-10-17T13:40:37.803566 | Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops Cimdelirsen to inhibit the production of growth hormone receptor; IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. Ionis Pharmaceuticals, Inc. was incorporated in 1989 and is based in Carlsbad, California. | null | 3,444 |
US | IOO | PCX | ETF | USD | iShares Global 100 ETF | null | null | 75.08 | 3,827 | 4,138,218,496 | 2023-10-17T13:40:44.617872 | The fund generally invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified. | null | 3,445 |
US | IOR | ASE | EQUITY | USD | Income Opportunity Realty Investors, Inc. | Financial Services | Mortgage Finance | 11.15 | 121 | 46,477,768 | 2023-10-17T13:40:50.242475 | Income Opportunity Realty Investors, Inc., a Dallas-based real estate investment company, currently holds a portfolio of notes receivable. The Company invests in real estate through direct equity ownership and partnerships. | null | 3,446 |
US | IOSP | NMS | EQUITY | USD | Innospec Inc. | Basic Materials | Specialty Chemicals | 99.09 | 582 | 2,461,982,720 | 2023-10-17T13:40:57.662890 | Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, and metal extraction markets. The company's Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, as well as products to prevent loss of mud in drilling operations. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado. | null | 3,447 |
US | IOT | NYQ | EQUITY | USD | Samsara Inc. | Technology | Software - Infrastructure | 24.43 | 51,379 | 13,031,431,168 | 2023-10-17T13:41:05.452819 | Samsara Inc. provides solutions that connect physical operations data to its Connected Operations Cloud in the United States and internationally. The company's Connected Operations Cloud includes Data Platform, which ingests, aggregates, and enriches data from its IoT devices and has embedded capabilities for AI, workflows and analytics, alerts, API connections, and data security and privacy; and applications for video-based safety, vehicle telematics, apps and driver workflows, equipment monitoring, and site visibility. It serves transportation, wholesale and retail trade, construction, field services, logistics, utilities and energy, healthcare and education, manufacturing, food and beverage, and other industries, as well as government. The company was incorporated in 2015 and is based in San Francisco, California. | null | 3,448 |
US | IOVA | NGM | EQUITY | USD | Iovance Biotherapeutics, Inc. | Healthcare | Biotechnology | 3.57 | 395,059 | 927,924,800 | 2023-10-17T13:41:13.658824 | Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company's lead product candidate is lifileucel that is in Phase II clinical trial for the treatment of metastatic melanoma and cervical cancer. It also develops LN-145 for the treatment of metastatic non-small cell lung cancer; IOV-4001 for the treatment of melanoma non-small cell lung cancer; IOV-2001; and IOV-3001. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M.D. Anderson Cancer Center; Ohio State University; Centre hospitalier de l'Université de Montreal; Cellectis S.A.; Novartis Pharma AG; Melanoma Institute Australia; and Beth-Israel Deaconess Medical Center. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California. | null | 3,449 |
US | IP | NYQ | EQUITY | USD | International Paper Company | Consumer Cyclical | Packaging & Containers | 35.01 | 65,284 | 12,134,184,960 | 2023-10-17T13:41:19.616723 | International Paper Company produces renewable fiber-based packaging and pulp products in North America, Latin America, Europe, and North Africa. It operates through Industrial Packaging and Global Cellulose Fibers segment. The company's Industrial Packaging segment manufactures containerboards, including linerboard, medium, whitetop, recycled linerboard, recycled medium, and saturating kraft. Its Global Cellulose Fibers segment provides fluff, market, and specialty pulps that are used in absorbent hygiene products, such as baby diapers, feminine care, adult incontinence, and other non-woven products; tissue and paper products; and non-absorbent end applications, including textiles, filtration, construction material, paints and coatings applications. In addition, it sells its products directly to end users and converters, as well as through agents, resellers, and distributors. The company was founded in 1898 and is headquartered in Memphis, Tennessee. | null | 3,450 |
US | IPA | NGM | EQUITY | USD | ImmunoPrecise Antibodies Ltd. | Healthcare | Biotechnology | 1.35 | 5,921 | 34,571,920 | 2023-10-17T13:41:27.262649 | ImmunoPrecise Antibodies Ltd., together with its subsidiaries, operates as a biotherapeutic research and technology company in Canada and internationally. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, a positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes. The company also offers syngeneic cell line for immunization and screening; and peptide production for subsequent antibody discovery campaign. In addition, it provides B cell select platform which allows for the interrogation of animal antibody repertoire; screening of the immune repertoire of rabbits and chickens and select the desired antibody directly from the B cells; single step hybridoma, a semi-solid media to grow mouse and rat hybridomas; and DeepDisplay, a combination of transgenic animal platform and custom IPA phage display antibody selection. The company also offers phage display, a custom immune libraries from multiple species; and CAR development, an adaptable antibody which allows the inclusion of functional data early in the screening funnel. Further, it provides silico developability, a profiling toolset for antibody lead candidates; and vitro analytical tools for the study of various critical quality attributes. Additionally, the company offers LucinaTech, an antibody humanization to identify essential framework and CDR residues; antibody affinity maturation for therapeutic and diagnostic application; and antibody chimerization for cloning and production of variable antibody domain. It also provides Eurofins preclinical services; hybrid service model, a service model designed to reduce time and risk with custom technologies and applications; and breadth and depth to accelerate assay development, screening cascades, drug candidate validation, and new biotherapeutic concepts. The company was incorporated in 1983 and is headquartered in Victoria, Canada. | null | 3,451 |
US | IPAC | PCX | ETF | USD | iShares Core MSCI Pacific ETF | null | null | 54.92 | 1,976 | 1,627,789,312 | 2023-10-17T13:41:34.765784 | The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index which consists of securities from the following five countries or regions: Australia, Hong Kong, Japan, New Zealand and Singapore. | null | 3,452 |
US | IPAR | NMS | EQUITY | USD | Inter Parfums, Inc. | Consumer Defensive | Household & Personal Products | 124.44 | 730 | 3,969,463,296 | 2023-10-17T13:41:42.117483 | Inter Parfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products in the United States and internationally. It operates in two segments, European Based Operations and United States Based Operations. The company offers its fragrance and cosmetic products under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont, Van Cleef & Arpels, Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta, and Ungaro brands, as well as French Connection, Intimate, and Aziza names. It sells its products to department stores, specialty stores, duty free shops, beauty retailers, and domestic and international wholesalers, and distributors, as well as through e-commerce. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Inter Parfums, Inc. was founded in 1982 and is headquartered in New York, New York. | null | 3,453 |
US | IPAY | PCX | ETF | USD | ETFMG Prime Mobile Payments ETF | null | null | 38.66 | 43,180 | 357,013,792 | 2023-10-17T13:41:48.360135 | The index tracks the performance of the exchange-listed equity securities of companies across the globe that (i) engage in providing payment processing services or applications,(ii) provide payment solutions, (iii) build or provide payment industry architecture, infrastructure or software or, (iv) provide services as a credit card network. The fund invests at least 80% of its total assets in the component securities of the index and in ADRs and GDRs based on the component securities in the index. It is non-diversified. | null | 3,454 |
US | IPDN | NCM | EQUITY | USD | Professional Diversity Network, Inc. | Industrials | Staffing & Employment Services | 1.87 | 36 | 20,539,332 | 2023-10-17T13:41:53.857636 | Professional Diversity Network, Inc. operates online professional networking communities with career resources in the United States. It operates in three segments: Professional Diversity Network (PDN Network), National Association of Professional Women (NAPW Network), and RemoteMore USA (RemoteMore). The company offers online professional job seeking communities that offers recruitment services, such as single and multiple job postings, recruitment media, talent recruitment communities, corporate memberships, hiring campaign marketing and advertising, e-newsletter marketing, and research and outreach services to various cultural groups and employers. It also provides consumer advertising and consumer marketing solutions through advertising and job postings on its websites. In addition, the company operates a women-only professional networking organization; and offers companies with talented engineers to provide solutions to their software needs. The company was incorporated in 2003 and is headquartered in Chicago, Illinois. | null | 3,455 |
US | IPG | NYQ | EQUITY | USD | The Interpublic Group of Companies, Inc. | Communication Services | Advertising Agencies | 29.77 | 142,002 | 11,632,735,232 | 2023-10-17T13:41:59.637171 | The Interpublic Group of Companies, Inc. provides advertising and marketing services worldwide. It operates in three segments: Media, Data & Engagement Solutions, Integrated Advertising & Creativity Led Solutions, and Specialized Communications & Experiential Solutions. The Media, Data & Engagement Solutions segment provides media and communications services, digital services and products, advertising and marketing technology, e-commerce services, data management and analytics, strategic consulting, and digital brand experience under the IPG Mediabrands, UM, Initiative, Kinesso, Acxiom, Huge, MRM, and R/GA brand names. The Integrated Advertising & Creativity Led Solutions segment offers advertising, corporate, and brand identity services; and strategic consulting. Specialized Communications & Experiential Solutions segment provides public relations and other specialized communications services, events, sports and entertainment marketing, and strategic consulting. The company was formerly known as McCann-Erickson Incorporated and changed its name to The Interpublic Group of Companies, Inc. in `January 1961. The Interpublic Group of Companies, Inc. was founded in 1902 and is headquartered in New York, New York. | null | 3,456 |
US | IPGP | NMS | EQUITY | USD | IPG Photonics Corporation | Technology | Semiconductor Equipment & Materials | 94.89 | 3,437 | 4,488,497,152 | 2023-10-17T13:42:06.283038 | IPG Photonics Corporation develops, manufactures, and sells various high-performance fiber lasers, fiber amplifiers, and diode lasers used in various applications primarily in materials processing worldwide. The company's laser products include hybrid fiber-solid state lasers with green and ultraviolet wavelengths; fiber pigtailed packaged diodes and fiber coupled direct diode laser systems; high-energy pulsed lasers, multi-wavelength and tunable lasers, and single-polarization and single-frequency lasers; and high-power optical fiber delivery cables, fiber couplers, beam switches, chillers, scanners, and other accessories. It also provides erbium-doped fiber and Raman amplifiers, and integrated communications systems, which are deployed in broadband networks; and ytterbium and thulium specialty fiber amplifiers and broadband light sources. In addition, the company offers integrated laser systems; 2D compact flat sheet cutter systems and multi-axis systems; welding seam stepper and picker, a fiber laser welding tool; high precision laser systems; specialized fiber laser systems; and optical transceiver and transponder modules for data center, optical, and communications network of oil and gas utilities. Its laser solutions are also used in materials processing, communications, and medical and advanced applications. The company markets its products to original equipment manufacturers, system integrators, and end users through direct sales force, as well as through agreements with independent sales representatives and distributors. IPG Photonics Corporation was founded in 1990 and is headquartered in Oxford, Massachusetts. | null | 3,457 |
US | IPHA | NMS | EQUITY | USD | Innate Pharma S.A. | Healthcare | Biotechnology | 2.36 | 1,503 | 190,363,024 | 2023-10-17T13:42:12.082886 | Innate Pharma S.A., a biotechnology company, develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; Avdoralimab (IPH5401), an Anti-C5aR Antibody; IPH5201, a blocking antibody that is in Phase 1 clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; IPH6401, an BCMA-targeting NK cell engager; and IPH6101, a NKp46-based NK cell engager that targets CD123 proprietary multi-specific antibody format; and IPH62, an B7-H3-targeting NK cell engager. Its products in preclinical trials are IPH43, an anti-MICA/B ADC and IPH4501, an antibody drug conjugates (ADC); and IPH65, a tetra-specific proprietary antibody. The company has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. Innate Pharma S.A. was incorporated in 1999 and is headquartered in Marseille, France. | null | 3,458 |
US | IPI | NYQ | EQUITY | USD | Intrepid Potash, Inc. | Basic Materials | Agricultural Inputs | 21.51 | 5,642 | 287,139,936 | 2023-10-17T13:42:17.815961 | Intrepid Potash, Inc., together with its subsidiaries, engages in the extraction and production of the potash in the United States and internationally. It operates through three segments: Potash, Trio, and Oilfield Solutions. The company offers muriate of potash for various markets, such as agricultural market as a fertilizer input; the industrial market as a component in drilling and fracturing fluids for oil and gas wells, as well as an input to other industrial processes; and the animal feed market as a nutrient supplement. It also provides Trio, a specialty fertilizer that delivers potassium, sulfate, and magnesium in a single particle; water for oil and gas services industry; salt for various markets, including animal feed, industrial applications, pool salt, and the treatment of roads and walkways for ice melting or to manage road conditions; magnesium chloride for use as a road treatment agent for deicing and dedusting; brines for use in oil and gas industry to support well workover and completion activities; and metal recovery salts. Intrepid Potash, Inc. was founded in 2000 and is based in Denver, Colorado. | null | 3,459 |
US | IPO | PCX | ETF | USD | Renaissance IPO ETF | null | null | 31.43 | 6,875 | 188,616,240 | 2023-10-17T13:42:24.465811 | The fund seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the index. It normally invests at least 80% of its total assets in securities that comprise the index. The index is a portfolio of companies that have recently completed an initial public offering ("IPO") and are listed on a U.S. exchange. The fund is non-diversified. | null | 3,460 |
US | IPOS | PCX | ETF | USD | Renaissance International IPO ETF | null | null | 13.3399 | 479 | 6,205,763 | 2023-10-17T13:42:32.436465 | The fund normally invests at least 80% of its total assets in securities that comprise the index. The index is comprised of common stocks, depositary receipts, real estate investment trusts ("REITs") and partnership units. The fund may also invest up to 20% of its assets in certain futures, options, and swap contracts, cash and cash equivalents, as well as in common stocks not included in the index but which will help the fund track the index. It is non-diversified. | null | 3,461 |
US | IPSC | NMS | EQUITY | USD | Century Therapeutics, Inc. | Healthcare | Biotechnology | 1.66 | 297 | 101,003,360 | 2023-10-17T13:42:40.154049 | Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-102, a CAR-iT targeting CD19 + CD22 for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-107, an iPSC-derived Nectin-4 CAR gamma delta T-cell therapy product candidate; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania. | null | 3,462 |
US | IPVF | ASE | EQUITY | USD | InterPrivate III Financial Partners Inc. | Financial Services | Shell Companies | 10.78 | 3 | 84,308,008 | 2023-10-17T13:42:47.791277 | InterPrivate III Financial Partners Inc. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses. It focuses on the businesses in the financial services industry. The company was formerly known as InterPrivate II Financial Holdings Corp. and changed its name to InterPrivate III Financial Partners Inc. in January 2021. InterPrivate III Financial Partners Inc. was incorporated in 2020 and is based in New York, New York. | null | 3,463 |
US | IPW | NCM | EQUITY | USD | iPower Inc. | Consumer Cyclical | Internet Retail | 0.4802 | 215 | 14,292,865 | 2023-10-17T13:42:55.314883 | iPower Inc. operates as an online retailer and supplier of consumer home, garden, and pet products for commercial businesses and individuals in the United States. The company offers grow light systems; advanced heating, ventilation, and air conditioning systems; water pumps, heaters, chillers, and filters; nutrient and fertilizer delivery systems; and various growing media products. It also provides general gardening products, including environmental sensors and controls; and home products, which comprise commercial fans, floor and wall fans, storage and shelving units, and chairs. The company sells its products under the iPower and Simple Deluxe brand names through zenhydro.com, simpledeluxe.com, and various third-party online platforms. The company was formerly known as BZRTH Inc. and changed its name to iPower Inc. in September 2020. iPower Inc. was incorporated in 2018 and is based in Rancho Cucamonga, California. | null | 3,464 |
US | IPWR | NCM | EQUITY | USD | Ideal Power Inc. | Industrials | Electrical Equipment & Parts | 9.21 | 1,893 | 54,752,604 | 2023-10-17T13:43:01.206159 | Ideal Power Inc. focuses on the development and commercialization of its bidirectional bipolar junction TRANsistor solid-state switch technology. The company offers SymCool Power Module designed to meet low conduction loss needs of the solid-state circuit breaker market. It serves electric and hybrid electric vehicles, electric vehicle charging, renewable energy and energy storage system power converters, uninterruptible power supplies for data centers, industrial motor drives, solid-state circuit breakers, distribution and transmission switches and controls, and other industrial and military markets. The company was formerly known as Ideal Power Converters Inc. and changed its name to Ideal Power Inc. in July 2013. Ideal Power Inc. was incorporated in 2007 and is headquartered in Austin, Texas. | null | 3,465 |
US | IPX | NCM | EQUITY | USD | IperionX Limited | Basic Materials | Other Industrial Metals & Mining | 8.65 | 25 | 167,372,304 | 2023-10-17T13:43:07.291857 | IperionX Limited engages in exploration and development of its mineral properties in the United States. It holds a 100% interest in the critical minerals Titan project, which has the resource of titanium, rare earth, and zircon rich mineral sands covering approximately 11,071 acres of surface and associated mineral rights in Tennessee, the United States. The company also produces titanium products made from scrap titanium at industrial pilot facility in Utah, United States. It operates titanium business to support various industries, including consumer electronics, aerospace, space, defense, medical, bicycles, additive manufacturing, hydrogen, and automotive. The company was formerly known as Hyperion Metals Limited and changed its name to IperionX Limited in February 2022. IperionX Limited was incorporated in 2017 and is headquartered in Charlotte, North Carolina. | null | 3,466 |
US | IPXX | NGM | EQUITY | USD | Inflection Point Acquisition Corp. II | Financial Services | Shell Companies | 10.22 | 604 | 319,375,008 | 2023-10-17T13:43:13.847072 | Inflection Point Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2023 and is based in New York, New York. Inflection Point Acquisition Corp. II operates as a subsidiary of Inflection Point Holdings II LLC. | null | 3,467 |
US | IQ | NMS | EQUITY | USD | iQIYI, Inc. | Communication Services | Entertainment | 4.77 | 110,163 | 4,534,633,984 | 2023-10-17T13:43:20.663889 | iQIYI, Inc., together with its subsidiaries, provides online entertainment video services in the People's Republic of China. It offers various products and services, including online video, online games, online literature, animations, and other products. The company operates a platform that provides a collection of internet video content, such as professionally produced content licensed from professional content providers and self-produced content. It also offers membership, online advertising, content distribution, and live broadcasting services. In addition, the company operates iQIYI Show, a live broadcasting platform that enables users to follow their favorite hosts and shows in real time through live broadcasting; and iQIYI Lite, which offers an easy and quick access to the personalized videos based on their user preferences. Further, it is involved in the talent agency and IP licensing activities, as well as engages in developing a video community app. The company was formerly known as Qiyi.com, Inc. and changed its name to iQIYI, Inc. in November 2017. iQIYI, Inc. was incorporated in 2009 and is headquartered in Beijing, China. iQIYI, Inc. is a subsidiary of Baidu, Inc. | null | 3,468 |
US | IQDE | PCX | ETF | USD | FlexShares International Quality Dividend Defensive Index Fund | null | null | 19.3762 | 3 | 27,486,338 | 2023-10-17T13:43:26.722650 | The underlying index is designed to reflect the performance of a selection of companies that, in aggregate, provide exposure to a high-quality income-oriented universe of long-only international securities issued by non-U.S.-based companies. The fund will invest at least 80% of its total assets in the securities of the underlying index and in ADRs and GDRs based on the securities in the underlying index. | null | 3,469 |
US | IQDF | PCX | ETF | USD | FlexShares International Quality Dividend Index Fund | null | null | 21.44 | 22,604 | 516,571,168 | 2023-10-17T13:43:33.177062 | The index is designed to reflect the performance of a selection of companies that, in aggregate, provide exposure to a high-quality income-oriented universe of long-only international securities issued by non-U.S.- based companies. The fund will invest at least 80% of its total assets in the securities of the index and in ADRs and GDRs based on the securities in the index. | null | 3,470 |
US | IQDY | PCX | ETF | USD | FlexShares International Quality Dividend Dynamic Index Fund | null | null | 25.2969 | 2,116 | 68,157,744 | 2023-10-17T13:43:39.227392 | The index is designed to reflect the performance of a selection of companies that, in aggregate, provide exposure to a high-quality income-oriented universe of long-only international securities issued by non-U.S.-based companies. The fund will invest at least 80% of its total assets in the securities of the index and in ADRs and GDRs based on the securities in the index. | null | 3,471 |
US | IQI | NYQ | EQUITY | USD | Invesco Quality Municipal Income Trust | Financial Services | Asset Management | 8.36 | 6,886 | 437,872,544 | 2023-10-17T13:43:45.180555 | Invesco Quality Municipal Income Trust is a closed-ended fixed income mutual fund launched by Invesco Ltd. The fund is co-managed by Invesco Advisers, Inc., INVESCO Asset Management Deutschland GmbH, INVESCO Asset Management Limited, INVESCO Asset Management (Japan) Limited, Invesco Hong Kong Limited, INVESCO Senior Secured Management, Inc., and Invesco Canada Ltd. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade municipal securities which include municipal bonds, municipal notes, and municipal commercial paper. It employs fundamental analysis with bottom-up security selection approach to create its portfolio. The fund was previously known as Morgan Stanley Quality Municipal Income Trust. Invesco Quality Municipal Income Trust was formed on September 29, 1992 and is domiciled in the United States. | null | 3,472 |
US | IQLT | PCX | ETF | USD | iShares MSCI Intl Quality Factor ETF | null | null | 33.93 | 75,450 | 6,471,805,952 | 2023-10-17T13:43:52.464979 | The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index measures the performance of international developed large- and mid-capitalization stocks exhibiting relatively higher quality characteristics as identified through three fundamental variables: return on equity, earnings variability and debt-to-equity. | null | 3,473 |
US | IQV | NYQ | EQUITY | USD | IQVIA Holdings Inc. | Healthcare | Diagnostics & Research | 198.98 | 34,145 | 36,144,164,864 | 2023-10-17T13:44:00.103627 | IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and decentralized clinical trials, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was incorporated in 2016 and is headquartered in Durham, North Carolina. | null | 3,474 |
US | IR | NYQ | EQUITY | USD | Ingersoll Rand Inc. | Industrials | Specialty Industrial Machinery | 64.95 | 41,046 | 26,152,482,816 | 2023-10-17T13:44:05.994871 | Ingersoll Rand Inc. provides various mission-critical air, fluid, energy, specialty vehicle, and medical technologies in the United States, Europe, the Middle East, India, Africa, and the Asia Pacific. It operates through two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment designs, manufactures, markets, and services air and gas compression, vacuum, and blower products; fluid transfer equipment and loading systems; and power tools and lifting equipment, including associated aftermarket parts, consumables, air treatment equipment, controls, other accessories, and services under the under the Ingersoll Rand, Gardner Denver, Nash, CompAir, Elmo Rietschle, Robuschi, Emco Wheaton, and Runtech Systems brands. The Precision and Science Technologies segment designs, manufactures, and markets diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps; and gas boosters, hydrogen compression systems, automated liquid handling systems, odorant injection systems, controls, software, and other related components and accessories for liquid and gas dosing, transfer, dispensing, compression, sampling, pressure management, and flow control in specialized or critical applications under the Air Dimensions, Albin, ARO, Dosatron, Haskel, LMI, Maximus, Milton Roy, MP, Oberdorfer, Seepex, Thomas, Welch, Williams, YZ, and Zinnser Analytic brand names. This segment's products are used in medical, life sciences, industrial manufacturing, water and waste water, chemical processing, energy, food and beverage, agriculture, and other markets. It sells through an integrated network of direct sales representatives and independent distributors. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc. was founded in 1859 and is headquartered in Davidson, North Carolina. | null | 3,475 |
US | IRAA | NCM | EQUITY | USD | Iris Acquisition Corp | Financial Services | Shell Companies | 10.32 | 4,476 | 146,612,112 | 2023-10-17T13:44:13.731112 | Iris Acquisition Corp does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Tribe Capital Growth Corp I and changed its name to Iris Acquisition Corp in July 2022. Iris Acquisition Corp was incorporated in 2020 and is based in George Town, Cayman Islands. | null | 3,476 |
US | IRBT | NMS | EQUITY | USD | iRobot Corporation | Consumer Cyclical | Furnishings, Fixtures & Appliances | 38.39 | 3,387 | 1,070,915,136 | 2023-10-17T13:44:21.621986 | iRobot Corporation designs, builds, and sells robots and home innovation products in the United States, Europe, the Middle East, Africa, Japan, and internationally. The company offers floor care products, including Roomba floor vacuuming robots; Roomba accessories and consumables, such as the Clean Base Automatic Dirt Disposal, replacement dirt disposal bags for the Clean Base, filters, brushes, and batteries; Braava family of automatic floor mopping robots; and Braava accessories and consumables, which include cleaning solution, washable and disposable mopping pads, replacement tanks, and batteries, as well as subscription services. It also provides H1 Handheld Vacuum, a portable vacuum; H1 Handheld Vacuum accessories comprising filters, chargers, batteries, and an extension kit that converts the H1 Handheld Vacuum into a stick vacuum; air purifiers under the Aeris brand; Root robots to help children learn how to code; and Create 3, a mobile robot platform that offers an opportunity for educators, developers, and high-school and college students to program behaviors, sounds, movements, and add additional electronics, as well as sells filters and fabric covers. The company sells its products through chain stores and other national retailers, distributors, and resellers, as well as through its website and app, and e-commerce websites. iRobot Corporation was incorporated in 1990 and is headquartered in Bedford, Massachusetts. | null | 3,477 |
US | IRDM | NMS | EQUITY | USD | Iridium Communications Inc. | Communication Services | Telecom Services | 42.93 | 20,559 | 5,422,211,584 | 2023-10-17T13:44:29.862401 | Iridium Communications Inc. provides mobile voice and data communications services and products to businesses, the United States and international governments, non-governmental organizations, and consumers worldwide. The company offers postpaid mobile voice and data satellite communications; prepaid mobile voice satellite communications; push-to-talk; broadband data; and Internet of Things (IoT) services. It also provides hosted payload and other data services, such as satellite time and location services; and inbound connections from the public switched telephone network, short message, subscriber identity module, activation, customer reactivation, and other peripheral services. In addition, the company offers voice and data solutions comprising personnel tracking devices; asset tracking devices for equipment, vehicles, and aircrafts; beyond-line-of-sight aircraft communications applications; maritime communications applications; specialized communications solutions for high-value individuals; mobile communications and data devices for the military and intelligence agencies, such as secure satellite handsets, as well as netted voice, messaging, and paging services; and maintenance services for the United States government's dedicated gateway. Further, it provides satellite handsets, voice and data modems, broadband data devices, and IoT data devices; various accessories for its devices that include batteries, holsters, earbud headphones, portable auxiliary antennas, antenna adaptors, USB data cables, charging units, and others; and engineering and support services. Iridium Communications Inc. sells its products and services to commercial end users through a wholesale distribution network that include service providers, and value-added resellers and manufacturers. The company was formerly known as Iridium Holdings LLC and changed its name to Iridium Communications Inc. in September 2009. Iridium Communications Inc. is headquartered in McLean, Virginia. | null | 3,478 |
US | IREN | NMS | EQUITY | USD | Iris Energy Limited | Financial Services | Capital Markets | 3.31 | 98,491 | 225,913,504 | 2023-10-17T13:44:35.305328 | Iris Energy Limited owns and operates bitcoin mining data centers. The company was incorporated in 2018 and is headquartered in Sydney, Australia. | null | 3,479 |
US | IRIX | NGM | EQUITY | USD | IRIDEX Corporation | Healthcare | Medical Devices | 2.96 | 7,081 | 49,427,444 | 2023-10-17T13:44:43.275354 | IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California. | null | 3,480 |
US | IRM | NYQ | EQUITY | USD | Iron Mountain Incorporated | Real Estate | REIT - Specialty | 61.67 | 45,207 | 17,890,701,312 | 2023-10-17T13:44:50.716261 | Iron Mountain Incorporated (NYSE: IRM) is a global leader in innovative storage, data center infrastructure, asset lifecycle management and information management services. Founded in 1951 and trusted by more than 225,000 customers worldwide, Iron Mountain helps customers CLIMB HIGHER to transform their businesses. Through a range of offerings including digital transformation, data centers, secure records storage, information management, asset lifecycle management, secure destruction, and art storage and logistics, Iron Mountain helps businesses bring light to their dark data, enabling customers to unlock value and intelligence from their stored digital and physical assets at speed and with security, while helping them meet their environmental goals. | null | 3,481 |
US | IRMD | NCM | EQUITY | USD | IRadimed Corporation | Healthcare | Medical Devices | 38.94 | 775 | 494,025,856 | 2023-10-17T13:44:58.589027 | IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida. | null | 3,482 |
US | IRNT | PNK | EQUITY | USD | IronNet, Inc. | Technology | Software - Infrastructure | 0.0002 | 93,750 | 22,355 | 2023-10-17T13:45:06.424342 | IronNet, Inc. designs and develops solutions for cyber-attacks. The company offers IronDefense, an advanced network detection and response solution that provides behavior-based and AI-driven analytics at the network level to detect anomalous activity at individual enterprises and prioritize the threats in its network; and IronDome, a threat-exchange solution that enables collective defense member enterprises to actively exchange individual anonymized cyber anomalies at machine speed in a community of public-private peers. It also provides a suite of technologies that provide real-time threat assessment and updates, behavioral modeling, big data analytics, and proactive threat detection and response capabilities; and consulting and training programs to protect against current and emerging cyber-threats. The company's services include cyber operations center, governance and maturity, cybersecurity readiness, incident response, and training services. It serves enterprise, defense, healthcare, government, and energy and utilities industries. The company was incorporated in 2014 and is headquartered in McLean, Virginia with additional offices in Raleigh, North Carolina; London, United Kingdom; and Singapore. On October 12, 2023, IronNet, Inc. along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. | null | 3,483 |
US | IRON | NGM | EQUITY | USD | Disc Medicine, Inc. | Healthcare | Biotechnology | 46.96 | 136 | 1,070,900,480 | 2023-10-17T13:45:13.943309 | Disc Medicine, Inc., together with its subsidiaries, operates as a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and MWTX-003 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts. | null | 3,484 |
US | IROQ | NCM | EQUITY | USD | IF Bancorp, Inc. | Financial Services | Banks - Regional | 14.23 | 1 | 47,736,384 | 2023-10-17T13:45:21.672009 | IF Bancorp, Inc. operates as the savings and loan holding company for Iroquois Federal Savings and Loan Association that provides a range of banking and financial services to individual and corporate clients. The company offers various deposit accounts, including savings accounts, certificates of deposit, money market accounts, commercial and personal checking accounts, individual retirement accounts, and health savings accounts. It provides loans comprising one- to four-family residential mortgage loans; multi-family mortgage loans; commercial real estate loans, such as farm loans; home equity lines of credit; commercial business loans; and consumer loans primarily comprising automobile loans, as well as construction loans and land development loans. In addition, the company sells property and casualty insurance, as well as offers annuities; mutual funds; individual and group retirement plans; life, disability, and health insurance; individual securities; managed accounts; and other financial services. Further, it invests in securities; and provides ATM, online banking and bill pay, mobile banking, ACH origination, remote deposit capture, and telephone banking services. IF Bancorp, Inc. was founded in 1883 and is headquartered in Watseka, Illinois. | null | 3,485 |
US | IRRX | NYQ | EQUITY | USD | Integrated Rail and Resources Acquisition Corp. | Financial Services | Shell Companies | 10.95 | 807 | 133,958,040 | 2023-10-17T13:45:27.236703 | Integrated Rail and Resources Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in railroad companies in North America. Integrated Rail and Resources Acquisition Corp. was incorporated in 2021 and is based in Winter Park, Florida. | null | 3,486 |
US | IRS | NYQ | EQUITY | USD | IRSA Inversiones y Representaciones Sociedad Anónima | Real Estate | Real Estate Services | 6.53 | 480 | 1,395,007,104 | 2023-10-17T13:45:33.134865 | IRSA Inversiones y Representaciones Sociedad Anónima, together with its subsidiaries, engages in the diversified real estate activities in Argentina. The company is involved in the acquisition, development, and operation of shopping malls, office buildings, and other non-shopping mall properties primarily for rental purposes. It also acquires and operates luxury hotels under the Intercontinental, Libertador, and Llao Llao names; develops and sells residential properties; and acquires undeveloped land reserves for future development or sale. The company was incorporated in 1943 and is headquartered in Buenos Aires, Argentina. IRSA Inversiones y Representaciones Sociedad Anónima is a subsidiary of Cresud S.A.C.I.F. y A. | null | 3,487 |
US | IRT | NYQ | EQUITY | USD | Independence Realty Trust, Inc. | Real Estate | REIT - Residential | 13.93 | 40,898 | 3,225,710,080 | 2023-10-17T13:45:38.722141 | Independence Realty Trust, Inc. (NYSE: IRT) is a real estate investment trust that owns and operates multifamily communities, across non-gateway U.S. markets including Atlanta, GA, Dallas, TX, Denver, CO, Columbus, OH, Indianapolis, IN, Raleigh-Durham, NC, Oklahoma City, OK, Nashville, TN, Houston, TX, and Tampa, FL. IRT's investment strategy is focused on gaining scale near major employment centers within key amenity rich submarkets that offer good school districts and high-quality retail. IRT aims to provide stockholders attractive risk-adjusted returns through diligent portfolio management, strong operational performance, and a consistent return on capital through distributions and capital appreciation. | null | 3,488 |
US | IRTC | NMS | EQUITY | USD | iRhythm Technologies, Inc. | Healthcare | Medical Devices | 84.36 | 9,087 | 2,605,202,944 | 2023-10-17T13:45:44.470068 | iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California. | null | 3,489 |
US | IRWD | NMS | EQUITY | USD | Ironwood Pharmaceuticals, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 9.8 | 115,939 | 1,555,609,088 | 2023-10-17T13:45:51.960047 | Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS name in the United States, Mexico, Japan, and China, as well as under the CONSTELLA name in the Canada and European countries. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of primary biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts. | null | 3,490 |
US | ISCB | PCX | ETF | USD | iShares Morningstar Small-Cap ETF | null | null | 46.2105 | 269 | 197,625,680 | 2023-10-17T13:45:59.708927 | The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of stocks issued by small-capitalization companies that have exhibited both “growth” and “value” characteristics as determined by Morningstar, Inc.’s (“Morningstar” or the “index provider”). | null | 3,491 |
US | ISCF | PCX | ETF | USD | iShares MSCI Intl Small-Cap Multifactor ETF | null | null | 28.8731 | 5,283 | 546,752,832 | 2023-10-17T13:46:06.105587 | The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. | null | 3,492 |
US | ISCG | PCX | ETF | USD | iShares Morningstar Small-Cap Growth ETF | null | null | 37.93 | 2,018 | 377,148,224 | 2023-10-17T13:46:13.459221 | The fund will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index measures the performance of U.S. stocks issued by small-capitalization companies that have exhibited above-average “growth” characteristics as determined by Morningstar, Inc.’s proprietary index methodology. | null | 3,493 |
US | ISCV | PCX | ETF | USD | iShares Morningstar Small-Cap Value ETF | null | null | 50.79 | 985 | 362,733,376 | 2023-10-17T13:46:19.642538 | The fund will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of U.S. stocks issued by small-capitalization companies that have exhibited above-average “value” characteristics as determined by Morningstar, Inc.’s proprietary index methodology. | null | 3,494 |
US | ISD | NYQ | EQUITY | USD | PGIM High Yield Bond Fund, Inc. | Financial Services | Asset Management | 11.38 | 7,756 | 377,127,648 | 2023-10-17T13:46:26.251628 | PGIM High Yield Bond Fund, Inc. is a close ended fixed income mutual fund launched and managed by Prudential Investments LLC. The fund is co-managed by Prudential Investment Management, Inc. It invests in the fixed income markets of the United States. The fund primarily invests in a diversified portfolio of high yield fixed income instruments that are rated below investment grade (Ba1 or lower by Moody's Investors Service, Inc. or BB+ or lower by Standard & Poor's Ratings Services). It seeks to invest in securities across all maturities, while attempting to maintain a weighted average portfolio duration of three years or less. The fund employs fundamental analysis to make its investments. It does not invest in municipal debt obligations, asset backed securities, or mortgage backed securities. PGIM High Yield Bond Fund, Inc. was formed on April 30, 2012 and is domiciled in the United States. | null | 3,495 |
US | ISDR | ASE | EQUITY | USD | Issuer Direct Corporation | Technology | Software - Application | 17.25 | 756 | 65,060,280 | 2023-10-17T13:46:32.159631 | Issuer Direct Corporation operates as a communications and compliance company, provides solutions for both public relations and investor relations professionals in the United States and internationally. The company provides press release distribution, media databases, media monitoring, and newsrooms through media advantage platform; ACCESSWIRE, a news dissemination and media outreach service; and VisualWebcaster Platform, a cloud-based webcast, webinar, and virtual meeting platform that delivers live and on-demand streaming of events to audiences of various sizes, as well as allows customers to create, produce, and deliver events. It also offers professional conference and events software, a mobile app that offers organizers, issuers, and investors to register, request, and approve one-on-one meetings, as well as manage schedules, perform event promotion and sponsorship, print attendee badges, and manage lodging; and investor relations content network, a series of data feeds, which include news feeds, stock feeds, fundamentals, regulatory filings, corporate governance, and other components. In addition, the company provides whistleblower hotline, a system that delivers secure notifications and basic incident workflow management processes that align with a company's corporate governance whistleblower policy; stock transfer module, which offers access to real-time information about their shareholders, stock ledgers, and reports, as well as issues new shares; and proxy module, a real-time voting platform for customers and their shareholders of record. It serves public and private companies, mutual funds, law firms, brokerage firms, investment banks, individuals, and other institutions. Issuer Direct Corporation was incorporated in 1988 and is headquartered in Raleigh, North Carolina. | null | 3,496 |
US | ISIG | null | null | null | null | null | null | null | null | null | null | null | error | 3,497 |
US | ISPC | NCM | EQUITY | USD | iSpecimen Inc. | Healthcare | Diagnostics & Research | 0.49 | 1,210 | 4,442,085 | 2023-10-17T13:46:38.450778 | iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts. | null | 3,498 |
US | ISPO | NGM | EQUITY | USD | Inspirato Incorporated | Consumer Cyclical | Travel Services | 4.92 | 13,786 | 309,187,360 | 2023-10-17T13:46:46.577311 | Inspirato Incorporated, together with its subsidiaries, operates as a subscription-based luxury travel company. The company provides affluent travelers access to a portfolio of curated luxury vacation homes, and accommodations at luxury hotels and resorts, as well as luxury safaris, cruises, custom-designed (bucket list) itineraries, and other experiences. It is also involved in solving critical pain points for hospitality suppliers seeking to monetize their property with rental income. In addition, the company offers Inspirato Real Estate, a platform to find, buy, own, and enjoy a luxury vacation home; Inspirato for Good, an easy-to-use, no-commitment platform designed to help nonprofit organizations accelerate funding results; Inspirato for Business, a business-to-business channel through which subscription and travel products are sold directly to businesses seeking to leverage luxury accommodations to recruit, retain, and reward their employees. The company was founded in 2010 and is headquartered in Denver, Colorado. | null | 3,499 |
US | ISPR | NCM | EQUITY | USD | Ispire Technology Inc. | Consumer Defensive | Tobacco | 8.89 | 3,885 | 488,220,160 | 2023-10-17T13:46:52.625722 | Ispire Technology Inc. researches, develops, designs, commercializes, sales, markets, and distributes e-cigarettes and cannabis vaping products worldwide. The company was founded in 2019 and is based in Los Angeles, California. Ispire Technology Inc. operates as a subsidiary of Pride Worldwide Investment Limited. | null | 3,500 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.